CAN, A. And Coskun, H. 2020. The rationale of using mesenchymal stem cells in patients withCOVID-19-related acute respiratory distress syndrome: What to expect. STEM CELLS TRANSLATIONAL MEDICINE , vol.9, no.11 , 1287-1302.

CAN, A., & Coskun, H., (2020). The rationale of using mesenchymal stem cells in patients withCOVID-19-related acute respiratory distress syndrome: What to expect. STEM CELLS TRANSLATIONAL MEDICINE , vol.9, no.11, 1287-1302.

CAN, ALP, And Hakan Coskun. "The rationale of using mesenchymal stem cells in patients withCOVID-19-related acute respiratory distress syndrome: What to expect," STEM CELLS TRANSLATIONAL MEDICINE , vol.9, no.11, 1287-1302, 2020

CAN, ALP And Coskun, Hakan. "The rationale of using mesenchymal stem cells in patients withCOVID-19-related acute respiratory distress syndrome: What to expect." STEM CELLS TRANSLATIONAL MEDICINE , vol.9, no.11, pp.1287-1302, 2020

CAN, A. And Coskun, H. (2020) . "The rationale of using mesenchymal stem cells in patients withCOVID-19-related acute respiratory distress syndrome: What to expect." STEM CELLS TRANSLATIONAL MEDICINE , vol.9, no.11, pp.1287-1302.

@article{article, author={ALP CAN And author={Hakan Coskun}, title={The rationale of using mesenchymal stem cells in patients withCOVID-19-related acute respiratory distress syndrome: What to expect}, journal={STEM CELLS TRANSLATIONAL MEDICINE}, year=2020, pages={1287-1302} }